Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Trademark Information
Application ID
Status
Sub Status
Date of Application
16 September 2022
Classes
5
Proprietor
Plot No 99 B, Lonavala Industrial Co Operative Estate Ltd, Nangargaon Lonawala Pune Mh 410401 In
Attorney
Stratjuris Law Partners[39301]
Office 301, Westport, Pan Card Club Road, Baner, Pune 411045. Mh.
Type
Word
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
Valid / Upto
Description
[Class : 5] Medical Diagnostic Reagents; Drug Testing Kits Containing Primarily Medical Diagnostic Reagents And Assays For Testing Body Fluids; Specimen Collection Kits For Use In Virus Testing Consisting Primarily Of Swabs For Medical Purposes; Veterinary Diagnostic Reagents; Pharmaceutical Preparations For Diagnostic Purposes; Diagnostic Kits Consisting Primarily Of Monoclonal Antibodies, Buffers, And Reagents For Use In Disease Testing; Nucleic Acid Sequences For Medical And Veterinary Purposes; Medical Diagnostic Test Strips; Diagnostic Preparations For Medical Purposes For Detecting Genetic Predispositions; Diagnostic Biomarkers For Use In Assessment Of Genomic Analysis For Medical Use; Diagnostic Preparations For Medical Purposes For Detecting Mutation In Prion Genes; Pregnancy Test Kits, Reagents For High Performance Liquid Chromatography Or High Pressure Liquid Chromatography Method
Sign In to Follow Application
All Documents & Correspondence
All Documents & Correspondence
Uploaded Documents
| 1 | TM-A(TRADE MARKS APPLICATION) | 16 Sep 2022 |
| 2 | Journal Copy | 22 Jun 2023 |
| 3 | TM-O(NOTICE OF OPPOSITION) | 19 Jul 2023 |
| 4 | TM-O(NOTICE OF OPPOSITION) | 01 Sep 2023 |
| 5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 05 Sep 2023 |
Correspondence and Notices
| 1 | Opposition Notice | 15869808 | 6138659 | 19 Aug 2023 |
| 2 | Opposition Counter Statement | 16766515 | 6378683 | 09 Dec 2023 |
| 3 | Opposition Notice | 16912502 | 6407628 | 22 Dec 2023 |
| 4 | Opposition Counter Statement | 17557687 | 6593024 | 27 Feb 2024 |